Prev Close | 7.42 |
Day Low/High | 7.41 / 7.78 |
52 Wk Low/High | 5.91 / 12.63 |
Prev Close | 7.42 |
Day Low/High | 7.41 / 7.78 |
52 Wk Low/High | 5.91 / 12.63 |
Exchange | NASDAQ |
Shares Outstanding | 280.16B |
Market Cap | 2.08B |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
Insiders have an edge in this complex sector, so it's worth checking them out.
Egalet, Portola Pharmaceuticals and Amicus Therapeutics hold promise for improvement.
Veterinary drug play Aratana Therapeutics is among the potential solid performers next year.
Small biotech tanked on weak earnings, but still seems promising.
These are the biggest errors that I've made over the years.
These 5 stocks all have positive catalysts on the horizon.
These 5 stocks all have positive catalysts on the horizon.
As Brexit turmoil calms down, let's get back to small cap stocks.
Warren Buffett is satisfied with his IBM holdings, but is Jim Cramer satisfied with the stock? Not exactly.
Momentum is elusive, but speculation is still healthy.
Momentum is lacking for new highs.
Biotechs are still bubbly in 'stock pickers' market.
The answer is blowing in the currency headwind.
Be wary of any early session strength.
Day-timeframe traders should be concerned with supply.
The market's oil worries are long forgotton.
Not a big day for the indices, but the underlying action improved.
"Everything must be fine."